Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2026-01-05 00:00:00 ET · period of report 2025-12-31 · accession 0001437749-26-000373 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | 2025-12-31 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | A - Grant | $0.46 | +2,500 | 105.3K | +2% | +$1,150 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | A | A | 2,500 | $0.46 | 105,275 | D | — | — | (F2) Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants. |